Security key
78667J108
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)
CUSIP: 78667J108
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
- Total 13F shares
- 51,167,791
- Total 13F value
- $277,852,513
- Share change
- -382,185
- Put/Call ratio
- 44%
- SEC-reported price per share
- $5.43
- Number of holders
- 173
- Value change
- -$6,197,488
- Number of buys
- 68
- Number of sells
- 80
- Shares outstanding
- 62,650,155
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q4 2024
Institutions
173
Top holders
10
SAGE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Sage Therapeutics, Inc. SEC filings
Sage Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 78667J108
Recent filing periods:
Ownership snapshot
Top reported holders of SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RTW INVESTMENTS, LP
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F
13D/G
Lead comparable stake: 4.9%
13D/G row: RTW INVESTMENTS, LP
Showing 1-6 of 15 holder rows.
Quick read
RTW INVESTMENTS, LP leads the comparable SEC ownership view at 4.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
RTW INVESTMENTS, LP
4.9%
VANGUARD GROUP INC
9.2%
BlackRock, Inc.
8.6%
FMR LLC
8.4%
Bellevue Group AG
7.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
13D/G
Company
|
4.9%
from 13D/G
|
$40,372,074
5,591,700 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
9.2%
|
$41,590,443
5,760,449 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
8.6%
|
$38,922,391
5,390,913 shares
|
— | 30 Sep 2024 |
| FMR LLC |
13F
Company
|
8.4%
|
$38,057,401
5,271,108 shares
|
— | 30 Sep 2024 |
| Bellevue Group AG |
13F
Company
|
7.1%
|
$32,206,203
4,460,693 shares
|
— | 30 Sep 2024 |
| STATE STREET CORP |
13F
Company
|
4.7%
|
$21,127,446
2,926,239 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
173
Shares
51,167,791
Rows available
173
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
171
Q4 2024 holders
173
Holder diff
2
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend